Highland Private Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-9,869
Closed -$866K 160
2018
Q1
$866K Buy
+9,869
New +$901K 0.53% 52

Other funds holding XBI

Highland Private Wealth Management's XBI Position: Q2 2018 in Review

Highland Private Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2018, closing a stake of 9,869 shares — an estimated $866K sold.

Highland Private Wealth Management first reported a position in XBI in Q1 2018 and held it in 1 quarter. The position peaked at $866K in Q1 2018. 431 funds tracked by Wall St. Rank hold XBI as of Q2 2018.

  • Highland Private Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2018 after selling out during the quarter.
  • Highland Private Wealth Management sold 9,869 State Street SPDR S&P Biotech ETF shares in Q2 2018, an estimated $866K.
  • Highland Private Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and held it in 1 quarter.
  • Highland Private Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $866K in Q1 2018.
  • 431 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2018.

Based on Highland Private Wealth Management's 13F filing for Q2 2018, filed 7 Aug 2018.